Piperazine (CAS 110-85-0) is a cyclic ethylene amine with two secondary amine groups, functioning as a critical intermediate across pharmaceuticals, agrochemicals, and industrial manufacturing. The global piperazine market was valued at approximately US$88.5 million in 2024 and is projected to reach US$102 million by 2031, growing at a CAGR of 2.1%. Piperazine anhydrous represents the largest product segment at roughly 76% of the market, with the pharmaceutical industry as the leading application. For exporters, traders, and procurement specialists, a structured piperazine global buyers list is not merely a directory—it is a strategic asset. This guide breaks down the buyer landscape by industry vertical, regional trade patterns, regulatory requirements, and practical…